Single-agent dabrafenib for BRAFV600E-mutated histiocytosis

Haematologica. 2018 Apr;103(4):e177-e180. doi: 10.3324/haematol.2017.185298. Epub 2018 Feb 22.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Aged
  • Child
  • Female
  • Histiocytosis / drug therapy*
  • Humans
  • Imidazoles / therapeutic use*
  • Male
  • Middle Aged
  • Mutation*
  • Oximes / therapeutic use*
  • Proto-Oncogene Proteins B-raf / genetics*
  • Treatment Outcome
  • Young Adult

Substances

  • Imidazoles
  • Oximes
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf
  • dabrafenib